Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Eikon Therapeutics, Shein, and 370+ companies. 5-min read every Tuesday.
Drug discovery company using real-time single-molecule microscopy to unlock previously undruggable targets.
| Industry | Biotechnology |
| Stage | Series A |
| IPO Status | Private |
| Valuation | $3.25B |
| Total Funding | $771M |
| Headquarters | Hayward, CA |
Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.
| Industry | E-Commerce |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $30-50B |
| Total Funding | $5.2B |
| Headquarters | Singapore |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Eikon Therapeutics is valued at $3.25B. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Eikon Therapeutics is currently private. Shein filed an S-1 in June 2024 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Eikon Therapeutics has raised $771M. Shein has raised $5.2B.
Eikon Therapeutics operates in Biotechnology, while Shein operates in E-Commerce.
Eikon Therapeutics is a Biotechnology company valued at $3.25B with $771M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Eikon Therapeutics and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.